40 results
Thumbnail

D2.100 - The usefulness of the forced oscillation technique in the diagnosis of bronchial asthma in seniors

Thumbnail

D2.111 - Wheeze phenotypes in infants whose mothers have asthma

Thumbnail

D2.99 - A mechanosensitive cytoskeleton protein talin2 involved in asthma pathogenesis

Thumbnail

D2.102 - Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma

Thumbnail

D2.103 - Exploring association between lung function, asthma and epigenetic predisposition to obesity

Thumbnail

D2.104 - Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma

Thumbnail

D2.105 - Clinical remission of severe asthma: 5-year follow-up

Thumbnail

D2.106 - Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness

Thumbnail

D2.107 - Effect of n-3 long-chain polyunsaturated fatty acid and vitamin D supplementation on human lung organoids

Thumbnail

D2.108 - Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain

Thumbnail

D2.109 - Interleukin-17A gene polymorphism contribute to the elderly asthma susceptibility: evidences from a case-control study

Thumbnail

D2.110 - MicroRNA Signatures of Pediatric Obesity-Associated Asthma: Identifying Molecular Links Between Obesity and Asthma in Children

Thumbnail

D2.112 - The Impact of Obesity in Asthma and Small Airway Dysfunction: Prevalence, Clinical characteristics, and Predictors

Thumbnail

D2.114 - Insights from the BREATHE Study: Comorbidity Burden and Biomarker Trends in Severe Asthma Patients

Thumbnail

D2.294 - Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023

Thumbnail

D2.295 - Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters

Thumbnail

D2.296 - Allergic contact dermatitis caused by a oxybutynin in a transdermal patch

Thumbnail

D2.297 - SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

Thumbnail

D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway

Thumbnail

D2.300 - Fixed Drug Eruption related to the use of NSAIDs